The British biotech business is presently preparing a Stage 1 test, which will certainly start in very early 2027 to evaluate the lead prospect as a therapy for cervical cancer cells and head and neck cancer cells.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/lift-biosciences-appoints-new-ceo-will-open-a-new-front-against-immunotherapy/